Seizing control of fragile X syndrome (2020)
Attributed to:
Targeting ERK and mTOR for the treatment of fragile X syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aba2902
Publication URI: http://dx.doi.org/10.1126/scitranslmed.aba2902
Type: Journal Article/Review
Parent Publication: Science Translational Medicine
Issue: 524